ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

NUS vs HLF // EV/EBITDA & P/E VALUATION

Nu Skin Enterprises Inc. (NYSE) VS. Herbalife Ltd. (NYSE) • 15-METRIC TALLY: NUS 5 — HLF 6
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NUS VS. HLF) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC NUS HLF SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 69.40% 77.90% -8.50 HLF /gross-margins <GO>
Return on Invested Capital (ROIC) 6.70% 34.40% -27.70 HLF /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — 5.4x — TIE /valuation <GO>
Free Cash Flow Yield 20.15% 18.66% +1.49 NUS /fcf-yield <GO>
Operating Margin 4.40% 9.50% -5.10 HLF /operating-margins <GO>
Net Profit Margin 10.80% 4.50% +6.30 NUS /net-margins <GO>
Revenue Growth (YoY) -14.30% 0.90% -15.20 HLF /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 5.18% 0.00% +5.18 NUS /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.54 2.39 +1.15 NUS /balance-sheet <GO>
Piotroski F-Score Quality 7/9 6/9 +1.00 NUS /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 43.2 47.5 -4.36 HLF /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 5.5x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $228.3M $1.36B -$1.13B HLF /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR NUS REV HLF REV NUS GROSS % HLF GROSS % NUS FCF HLF FCF
FY 2025 $1.49B $5.04B 69.4% 77.9% $46.0M $252.9M
FY 2024 $1.73B $4.99B 68.2% 77.9% $70.2M $163.4M
FY 2023 $1.97B $5.06B — — $118.6M $357.5M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NUS // BETA —
HLF // BETA —